Breaking News, Promotions & Moves

Metrics Adds Formulation Scientist

DeHart to oversee formulation and manufacturingof clinical trial materials

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dr. Michael DeHart has joined Metrics, Inc. as a new formulation scientist. Dr. DeHart will manage all aspects of personnel and operations related to formulating and manufacturing pharmaceutical materials for Phase I-III clinical trials. He is also responsible for scale up and validation of clinical trial materials, and manufacturing and packaging batches under cGMP guidelines. He will supervise technology transfers and serve as the company’s experimental design expert in both formulation development and process optimization.
 
Prior to joining the company, Dr. DeHart worked for several contract pharmaceutical manufacturing companies, where his responsibilities involved reverse engineering and developing analytical methods. Most recently, he was a development scientist at a commercial manufacturing site for Catalent Pharma Solutions, where he facilitated the technology transfer and scale up of solid oral dosage forms.
 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters